Anticancer activity of <i>Caesalpinia sappan</i> by downregulating mitochondrial genes in A549 lung cancer cell line

Nashi Widodo; Sapti Puspitarini; Muhammad Hermawan Widyananda; Adzral Alamsyah; Septian Tri Wicaksono; Masruri Masruri; Yoga Dwi Jatmiko

doi:10.12688/f1000research.76187.2

Home Browse Anticancer activity of Caesalpinia sappan by downregulating mitochondrial...

ALL Metrics

-

Views

-

Downloads

Get PDF

Get XML

Export

▬

✚

Research Article

Revised

Anticancer activity of Caesalpinia sappan by downregulating mitochondrial genes in A549 lung cancer cell line

[version 2; peer review: 2 approved]

Nashi Widodo ¹, Sapti Puspitarini¹, Muhammad Hermawan Widyananda¹, [...] Adzral Alamsyah¹, Septian Tri Wicaksono², Masruri Masruri³, Yoga Dwi Jatmiko¹

Nashi Widodo ¹, Sapti Puspitarini¹, [...] Muhammad Hermawan Widyananda¹, Adzral Alamsyah¹, Septian Tri Wicaksono², Masruri Masruri³, Yoga Dwi Jatmiko¹

PUBLISHED 25 Aug 2022

Author details Author details

¹ Biology Department, Faculty of Mathematics and Natural Sciences, Brawijaya University, Malang, Indonesia
² Faculty of Mathematics and Natural Sciences, Maulana Malik Ibrahim State Islamic University Malang, Malang, Indonesia
³ Chemistry Department, Faculty of Mathematics and Natural Sciences, Brawijaya University, Malang, Indonesia

Nashi Widodo
Roles: Conceptualization, Resources, Software, Supervision, Validation, Writing – Original Draft Preparation, Writing – Review & Editing

Sapti Puspitarini
Roles: Methodology, Project Administration, Writing – Original Draft Preparation, Writing – Review & Editing

Muhammad Hermawan Widyananda
Roles: Data Curation, Writing – Original Draft Preparation

Adzral Alamsyah
Roles: Data Curation, Formal Analysis, Investigation, Methodology, Validation, Writing – Original Draft Preparation

Septian Tri Wicaksono
Roles: Data Curation, Formal Analysis, Methodology

Masruri Masruri
Roles: Funding Acquisition

Yoga Dwi Jatmiko
Roles: Funding Acquisition

OPEN PEER REVIEW

REVIEWER STATUS

This article is included in the Cell & Molecular Biology gateway.

This article is included in the Oncology gateway.

Abstract

Background: The standardization and mechanism of action of Caesalpinia sappan as an anticancer agent are still lacking. This study aimed to understand the mechanism of action of C,sappan extract as an anticancer agent.
Methods: This study was conducted using the A549 lung cancer cell line to understand the mechanism of action of C. sappan extract as an anticancer agent. The cytotoxicity activity, cell cycle progression, apoptosis, protein-related apoptosis (i.e., BCL-2and BAX protein) assays, and RNA sequencing were performed level were measured. Moreover, the antioxidant activity, total flavonoids, and phenolics of C.sappan were also assessed.
Results: C.sappan has strong antioxidant activity (22.14 ± 0.93 ppm) total flavonoid content of (529.3 ± 4.56 mgQE/g), and phenolics content of (923.37 ± 5 mgGAE/g). The C.sappan ethanol extract inhibited cancer cell growth and arrested at G0/G1 phase of cell cycle, inducing apoptosis by increasing BAX/BCL-2 protein ratio in A549 lung cancer cell line. Furthermore, results from RNA sequencing analysis showed that C.sappan ethanol extract caused downregulation of genes acting on mitochondrial function including adenosine triphosphate (ATP) production and respiration.
Conclusions: This study demonstrated that C.sappan has the ability to inhibit cancer cell growth by inducing apoptosis and mitochondrial dysfunction in A549 cells.

Keywords

A549 cells, apoptosis, ATP production, Caesalpinia sappan, cytotoxicity, mitochondrial dysfunction

Corresponding author: Nashi Widodo

Competing interests: No competing interests were disclosed.

Grant information: This work was supported by the Directorate General Higher Education, Ministry of Research and Technology Republic of Indonesia, via a World Class Research grant assigned to Widodo, Yoga Dwi Jatmiko, and Masruri (grant number: 023/E4.1/AK.04.PT/2021).
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Copyright: © 2022 Widodo N et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite: Widodo N, Puspitarini S, Widyananda MH et al. Anticancer activity of Caesalpinia sappan by downregulating mitochondrial genes in A549 lung cancer cell line [version 2; peer review: 2 approved]. F1000Research 2022, 11:169 (https://doi.org/10.12688/f1000research.76187.2) First published: 11 Feb 2022, 11:169 (https://doi.org/10.12688/f1000research.76187.1) Latest published: 25 Aug 2022, 11:169 (https://doi.org/10.12688/f1000research.76187.2)

Revised Amendments from Version 1

The new version of this article describes in more detail the methods used in the study, such as cell culture media conditions, cytotoxicity formulas, and dosage details. In addition, the latest article provides new information compared to previous studies, namely providing the mechanism of C. sappan extract in eliminating the lung cancer cell line A549.

To read any peer review reports and author responses for this article, follow the "read" links in the Open Peer Review table.

Introduction

Lung cancer is one of the most dangerous and leading causes of death globally.¹ In 2020, there were 247,270 new cases of lung cancer in the United States, wherein 130,430 and 116,930 cases were from man and women, respectively. Additionally, there were 140,7230 deaths from lung cancer, in which 76,370 and 64,360 were man and women, respectively.² Lung cancer is the 14^th leading cause of death in Indonesia. Based on the WHO data (2018), the death rate due to lung cancer in Indonesia is 33,296, and there were 29,921 deaths from March to November 2020.³

Lung cancer treatment still relies on radiation and chemotherapy, especially for the treatment of metastatic lung cancer.⁴^,⁵ Current treatment regiments for lung cancer includes drugs such as gefitinib, nivolumab, and erlotinib or monoclonal antibodies (cetuximab, bevacizumab), which block the growth and spread of cancer by interfering with specific molecules involved in tumor growth and development.⁶ However, these treatments are relatively expensive; hence, using traditional herbal medicine is an alternative option. The development of herbal medicines as anticancer agents not yet been explores, and it lacks standardization. Thus, it is essential to study the mechanism of action of herbs that have been empirically used as cancer treatments for the development of phytopharmaceuticals.⁷

Secang (Caesalpinia sappan), a plant from the Caesalpiniaceae family which is often used as a traditional drink and natural dye in certain regions of Indonesia, primarly using the heartwood. Secang is known to contain the active compound brazilin in addition to various other compounds that contain antitumor, antibacterial, antiviral, antioxidant, and immunostimulant properties.⁵^,⁸ However, standardization and development of the use of C. sappan as an anticancer agent are still lacking. Therefore, this study aimed to analyze the effect of ethanol extract of secang (C. sappan) on lung cancer cell culture (A549 cell line) in inhibiting cell growth and study its mechanism.

Methods

Plant and extraction

Dry powder of C. sappan stem was purchased from UPT Materia Medica Batu, Batu, Indonesia. The microwave-assisted extraction method was used for powder extraction by dissolving the powder in ethanol in a 1:10 ratio (herb: solvent; w/v) using a holding temperature of 50°C, warming at 50°C for 5 mins, holding time of 10 mins, cool down of 5 mins, and power of 1500 W. The extract was filtered using filter paper and then evaporated using a rotary vacuum evaporator (Buchi: Buchi R-210 Rotavapor System). The extract was freeze-dried until a dried extract was obtained.

Cytotoxicity assay

The A549 (lung cancer cell line) cells were obtained from the Japanese Collection of Research Bioresources Cell Bank, Japan. The cells were cultured on complete medium (DMEM (Gibco: 12800-017) + 10% fetal bovine serum (Gibco: 10270-098) + 1% penicillin-streptomycin (Gibco: 15140-122)) and incubated at 37°C and 5% CO₂. The cytotoxicity activity of C. sappan ethanol extract was tested using WST-1 (Sigma: 11644807001) with 5% concentration (v/v medium). The A549 cells were seeded on 96-well plates to approximately 7.500 cells/well. The concentrations of C. sappan ethanol extract used were 10 μg/mL, 20 μg/mL, 40 μg/mL, 80 μg/mL, 160 μg/mL, and 320 μg/mL. Then the cells were treated for 24 h. The absorbance was measured using an ELISA reader (BioTek ELx808) at a wavelength of 450 nm. Cell viability was adjusted using Equation (1). The IC₅₀ value was calculated from linear regression of the cytotoxicity chart using Equation (2).

(1)

% viability of cells = (\frac{Abstreatment - Absblanko}{Abscontrol - Absblanko}) \times 100 %

Where Abscontrol: absorbance of control; Absblanko: absorbance of blanko; Abstreatment: absorbance of treatment.

(2)

Y = ax + b, where Y = 50 %; x = {IC}_{50} dose

Cell cycle, apoptosis, and BAX/BCL-2 ratio assay

The cells were seeded to approximately 75.000 cells/well into 24-well plates. The extract doses for the cell apoptosis assay were obtained from the IC₅₀ values that is 0 (untreated extract), 22.6, 45.2, and 90.4 µg/mL. After incubation for 24 h, the treated A549 cells were harvested and incubated with the dyes for 30 min. The cells were then analyzed using the flow cytometer (BD FACSCalibur) with CellQuest software version 6.0. The cells were dyed using propidium iodide (BioLegend: 421301) for cell cycle assay and tested using annexin-V/propidium iodide dyes (BioLegend: 640932) for the cell apoptosis assay. For the BAX/BCL-2 assay, the cells were tested using BAX (SantaCruz: sc-20067) and BCL-2 (SantaCruz: sc-20067) antibodies.

2,2–Diphenyl-1-picrylhydrazyl (DPPH) scavenging activity assay

Approximately 100 μL of C. sappan ethanol extract solution was added to 100 μL DPPH (Sigma: D9132) solution with 0.4 mM concentration in 96-well plates. The sample was incubated for 30 min, and absorbance was measured using an ELISA reader (BioTek ELx808) with λ = 490 nm. The inhibition percentage of scavenging activity was adjusted using Equation (3). The IC₅₀ value was calculated from linear regression of the cytotoxicity chart using Equation (2).

(3)

% inhibiton : (\frac{Abstreatment - Absblanko}{Abscontrol - Absblanko}) \times 100 %

Total flavonoids assay

Total flavonoids were estimated using the aluminum chloride colorimetric assay.⁹ Quercetin (MarkHerb) was used as the standard. Approximately 50 μL of Caesalpinia sappan ethanol extract or standard was added to 10 μL of AlCl₃ (Smartlab: A-2070) (10% w/v) followed by 150 μL of 96% ethanol solution (SmartLab). The solution was then added to 10 μL of CH₃COONa (Sigma) with a 1M concentration. The solution was incubated at room temperature for 40 min and protected from light. The absorbance was measured using an ELISA reader (BioTek ELx808) at a wavelenght of λ = 405 nm. Total flavonoid contents were expressed in terms of quercetin equivalent (standard curve equation of quercetin; $y = 0.0023 + 0.0583 R^{2} = 0.9992$ ) mg QE/g of dry extract.

Total phenolic assay

The total phenolic content was estimated using the Folin–Ciocalteu. A sample or standard of 100 μL was added to 1.0 mL of the Folin–Ciocalteu reagent (Merck: 1090010500) (a ready-to-use reagent diluted tenfold with distilled water). After 5 min, 1.0 mL of Na₂CO₃ (Merck: 1063921000) (7.5% w/v) was added to the mixture and incubated at room temperature for 90 min in dark conditions. Total phenolic content was measured using spectrophotometry in λ = 725 nm. Gallic acid (MarkHerb) was used as standard. Gallic acid was expressed in terms of gallic acid equivalent (standard curve equation of gallic acid) mg GAE/g of dry extract.

RNA extraction, preparation, and transcriptome sequencing

The cells were seeded with a density of 2.2 × 10⁶ cells in a 100-mm dish. The cells were treated with 0 (control) and 45.2 ug/mL (IC₅₀) extract and incubated for 24 h. RNA extraction processing was conducted at PT Genetika Science, Jakarta. Briefly, total RNA was extracted using the Quick RNA MiniPrep Kit (Zymo Research, R1057) as per the manufacturer’s instructions. The integrity, contaminant, quantitation, and purity of RNA samples were evaluated before further use. The preparation and transcriptome sequencing of RNA was conducted at NovogeneAIT Genomics, Singapore. Briefly, the library preparation for Eukaryotic mRNA using polyA enrichment method (NEB). Sequencing was created using Illumina NovaSeq 6000 PE150.

Results

Antioxidant activity, total phenol, and flavonoid content

Table 1 presents the antioxidant activity and total phenol and flavonoid content of C. sappan.⁴⁵ The results showed that C. sappan ethanol extract contains an abundant amount of phenol and flavonoid. Besides that, the antioxidant activity of C. sappan ethanol extract has low IC₅₀ or strong activity of antioxidant. Bioactive compounds of C. sappan include phenol and flavonoid groups which have pharmacological activities, such as antioxidant and anticancer properties.

Table 1. Antioxidant activity and total phenol and flavonoid content of the samples.

DPPH=2,2–Diphenyl-1-picrylhydrazyl.

Sample	IC₅₀ of DPPH scavenging (ppm)	Total phenol (mgGAE/g)	Total flavonoid (mgQE/g)
Caesalpinia sappan	22.14 ± 0.93	923.37 ± 5	529.3 ± 4.56

Anticancer activity of C. sappan against A549 cells line

The anticancer activity of C. sappan ethanol extract against A549 cells line was determined from cytotoxicity effect, capability inducing apoptosis, inhibiting cell cycle phase, and Bax/Bcl2 ratio. The cytotoxicity effect of C. sappan ethanol extract on A549 cells confirmed that C. sappan ethanol extract could inhibit the growth of A549 cells (Figure 1A). The calculated IC₅₀ value from Figure 1A was around 45.19 ± 1.704 μg/mL. The IC₅₀ value was used as basic concentration for apoptosis, cell cycle, and Bax/Bcl2 assays. The extract’s capability to induce apoptosis on A549 cells was determined by annexin-V/PI dyes and analyzed by flow cytometry. The apoptosis assay showed that the treatment of C. sappan ethanol extract on A549 cells for 24 h indicated that the apoptotic cell percentage was increased compared with controls (Figure 1B). The ability of C. sappan ethanol extract to inhibit the cell cycle in A549 cells was evaluated from cell cycle assay using PI dyes. The result indicated that the extract could induce cell cycle arrest in G0/G1 compared with control (Figure 1C). The Bax/Bcl2 assay was conducted to analyze the protein associated with to apoptosis. The level of Bax increased compared with that of the control after 24 h of incubation with C. sappan ethanol extract. Moreover, theBcl2 level decreased compared with that of the control after 24 h of incubation with the extract. The result demonstrated that the C. sappan ethanol extract could induce apoptosis in A549 cells by increasing the Bax/Bcl2 protein ratio (Figure 1D). Cell morphology observations showed results that were directly proportional to the anticancer activity assay. The population of cells in the control group (0 μg/mL) has a normal form of cancer cells. The 22.6 μg/mL group reduced the cell population density compared with the control group, whereas the 45.2 μg/mL group reduced the cell density and altered cell shape to smaller and rounder cells, indicating cell death. The 90.4 μg/mL group had dominant dead cells (Figure 1E).

Figure 1. Anticancer activity of C. sappan against A549 cells line.

(A) Cytotoxicity assay; (B) apoptosis assay; (C) cell cycle assay; (D) BAX-BCL-2 assay; (E) cell morphology microcopies.

Effect of C. sappan extract on the gene expression profile of A549 cells

RNA-seq analysis results showed differences in gene expression profiles between the control and those treated with the extractat its IC₅₀ value. Pearson correlation was used to verify the results of RNA sequencing, in which the replication was reliable and the sample selection was correct. Pearson correlation was constructed from all gene expression data (FPKM) in each sample. The R2 value of the same sample is 1, indicating a perfect correlation which means that the method and sample used are correct. The value of R2 between the control and IC₅₀ is 0.937, which means that it is strongly correlated but not identical. The correlation value of 0.937 indicates a difference in gene expression between the control and IC₅₀ (Figure 2A). The analysis of co-expression Venn diagrams showed that 486 genes were expressed in the control group, 427 genes were expressed in C. sappan extract treatment, and 11238 genes were co-expressed in both groups (Figure 2B). Box and whisker plot were constructed to compare the distribution of gene expression in the two samples. The results showed a not-too-distant difference overall. The difference is seen in the value of log2(fpkm+1) 10, indicating a difference in expression between samples (Figure 2C). Comparison of gene expression between the control and IC₅₀ can also be seen in the gene expression heatmap. The gene expression heatmap was constructed using Log2(FPKM+1) values summed with color; red and blue indicate high expression and low expression, respectively. From the heatmap, it can be observed that there are differences in gene expression between the control and IC₅₀ (Figure 2D).

Figure 2. Gene expression profile of A549 cells after C. sappan extract treatment for 24 h.

(A) Pearson correlation; (B) co-expression Venn diagrams; (C) gene expression distribution; (D) heatmap analysis.

Changes in gene expression profile due to the extract treatment affect the biological processes of A549

Volcano plot of gene expression from RNA-seq analysis showed that C. sappan extract treatment of A549 cells resulted in the upregulation of 388 genes and downregulation of 669 genes compared with the control group (Figure 3A). Functional annotations were constructed from genes that had a sixfold increased expression and those that had a sixfold decreased expression compared with controls. The genes that have decreased expression have a role in adenosine 5'-triphosphate (ATP) synthesis and mitochondrial respiration (Figure 3C and D). This indicates a decrease in the production of ATP by the mitochondria. This decrease in ATP production is thought to cause apoptosis and cell cycle arrest in A549 cells. Further, genes that experience an extreme increase in expression are involved in the process of hemostasis and attachment as the cells attempt to survive (Figure 3B and C). The increase in some genes levels involved in the cell growth is the cell survival mechanism in response against the toxicity of the extract. However, these cell survival efforts were insufficient due to ATP depletion, so the cells experienced apoptosis, as evidenced by previous results.

Figure 3. Gene expression profile affects the biological processes of A549 cells after C. sappan extract treatment for 24 h.

(A) Volcano plot; (B) biological processes for sixfold upregulation; (C) biological processes for sixfold up- and downregulation; (D) biological processes for sixfold downregulation.

Network analysis of sixfold up- and downregulated genes

Gene expression of A549 cells after treatment with C. sappan extract for 24 h is correlated with protein interactions that play a role in biological processes associated with cancer. Upregulated proteins play a role in cell adhesion, specifically, CDH15, CLDN6, and FMOD. In addition, there are also proteins, e.g., SLCA8A and GUCY2C, that interact with PDZD3, which play a role in maintaining intracellular ion homeostasis (Figure 4A). Although the proteins associated with cell survival are upregulated, the cells will die if the ATP concentration drastically drops. Meanwhile, proteins that play a role in the regulation of mitochondrial work are downregulated, including ARMCX1. In addition to proteins related to ATP production, proteins whose interactions with other proteins affect the growth of cancer cells are downregulated, including CEACAMP7 and RSPO4 that play a role in cancer cells; ZBTB8B that involved in cancer cell development; NXPH3 interacts with proteins associated with microtubule formation and metastasis; SOAT2 and FBXW12 proteins that interact with the cancer cell cycle and growth-related proteins (Figure 4B).

Figure 4. Protein interactions related to cancer on A549 cells after C. sappan extract treatment for 24 h.

The red mark for gene found upregulated or downregulated in the A549 cells after treatment with the extract. (A) 6-fold upregulate; (B) 6-fold downregulate.

Discussion

The ability of a substance as an anticancer agent can be seen from its ability to eliminate cancer cells. Cell death can be seen from various characteristics, including decreased cell viability, inhibited cell cycle processes, and increased apoptotic cells. Previous findings suggested that C. sappan extract reduced A549 cell viability but the mechanism didn’t revealed.¹⁰ This study provides a mechanism of C. sappan extract in eliminating the lung cancer cell line A549.

Herbal medicines have several functions in pharmacology due to their bioactive compound content. This study presents that the C. sappan contains a high phenol and flavonoid content. The phenolic group, including flavonoids and tannins, has proven to be anticancer agents¹¹ and have antioxidant¹² activity. The results indicated that one of the bioactive compounds could have therapeutic activity for several diseases, e.g., antioxidant and anticancer activities.

C. sappan ethanol extract was proven to induce cell death in A549 cells. The cytotoxicity of the extract in A549 cells was 45.19 ± 1.704 μg/mL, indicating it has strong cytotoxicity.¹³ This result is not far from the previous studies that treated T47D, PANC-1, and HeLa cells with C. sappan extract to obtain IC₅₀ values of 68.00, 43.6, and 40.88 μg/mL, respectively.¹⁴^-¹⁶ The extract could also significantly induce apoptosis by an analysis using Annexin-V. This apoptosis was verified by microscopic images and a high Bax/Bcl2 ratio. The apoptosis of A549 cells could be due to ATP depletion and mitochondrial dysfunction. Previous research has stated that hydroxy-chalcones group of compounds can cause ATP depletion, resulting in melanoma cell apoptosis.¹⁷ C. sappan extract also caused A549 cell arrest in the G1 phase, which was also thought to be due to ATP depletion. ATP is required in the cell cycle for the phosphorylation of the cyclin/cyclin-dependent kinase complex.¹⁸ The G1 phase is very sensitive to the availability of ATP. When the ATP content is too low, the cell will stop growing or prolong the duration of the phase until the amount of ATP is met.¹⁹

ATP is the main energy source for cells because it has a phosphoanhydride bond that contains a lot of energy.²⁰ Breaking this bond releases a huge amount of energy used for cellular processes.²¹ ATP is required for DNA replication, protein biosynthesis, biochemical transport, protein activation, and pathways in cells.²² ATP is synthesized in the mitochondria via oxidative phosphorylation that utilizes the proton gradient across the inner membrane of mitochondria.²³ The process involves electron transport, played by the protein complex I–IV.²⁴ Downregulating proteins that play a role in electron transport can reduce ATP production, resulting in the disruption of various cellular processes.²⁵ Previous research has suggested that prostate cancer cells can die due to ATP depletion in vitro.²⁶ In a previous study, downregulation of respiratory complex I mediated cell death.²⁵

The anticancer effect of C. sappan ethanol extract occurs via ATP depletion and mitochondrial dysfunction. The results of the functional annotation analysis of the RNA-seq showed that the proteins with decreased expression by sixfold compared to the control functioned as mitochondrial electron transport and ATP synthesis. Mitochondrial electron transport is played by the protein complex I–IV. RNA-seq results showed that in A549 cells, there was downregulation of the mitochondrial electron transport chain NADH to ubiquinone and the mitochondrial respiratory chain complex I assembly, both of which included protein complex I in the mitochondrial electron transport chain. Protein complex I transfers electrons from NADH to ubiquinone. Protein complex IV transfers electrons from cytochrome c to O₂ to produce H₂O. MET is played by protein complex I–IV. Meanwhile, upregulated genes have a role in cell adhesion and cell survival. Cell adhesion is needed by cancer cells for invasion and metastasis. Cellular adhesion is required for cell–cell interactions and interactions between cells with extracellular matrix components.²⁷ ATP depletion induces actin rearrangement, thereby reducing cell adhesion.²⁸ Cellular response to hypoxia is an adaptive response of cells due to a lack of oxygen to survive.²⁹ However, this biological process will not work in the presence of ATP depletion so that cells continue to undergo apoptosis, as happened in this study.

In addition to proteins that play a role in ATP synthesis, several proteins play a role in cancer growth that are downregulated. The downregulated protein is labeled in purple and in a larger font in Figure 4B. CD200R1 protein plays a role in modulating cancer immune microenvironments, which are generally overexpressed in NSCLC patients.³⁰ CD200R1, after binding to CD200, will suppress the antitumor response by modulating the activity of immune cells.³¹ CEACAM7 is a protein that plays a role in cell adhesion.³² RSPO4 is a protein that plays a role in activating the Wnt signaling pathway, which is an essential pathway for cell growth and development.³³ ARMCX1 plays a role in the regulation of mitochondrial transport.³⁴ The ZBTB8B protein interacts with proteins that play a role in mRNA processing and centrosome regulation during mitotic entry, such as, CPSF6, LSM, and KIF5B.³⁵^,³⁶ NXPH3 interacts with proteins related to the formation of microtubules such as TUBA1A and TUBA4A, where microtubules are indispensable during mitosis.³⁷ In addition, NXPH3 also interacts with CUL4A and the epithelial–mesenchymal transition-related protein that promotes cancer cell metastasis.³⁸ SOAT2 protein interacts with antiapoptotic protein BAG3.³⁹ FBXW12 interacts with SKP1 and IL22RA1, which plays a role in cell cycle progression and cancer cell growth induction.⁴⁰ Apart from downregulating genes, there are also several upregulating genes. As shown in the picture, upregulating genes play a role in survival, such as CDH15, CLDN6, and FMOD, which have an important role in cell adhesion.⁴¹^,⁴² SCL8A3 and PDZD3 proteins play a role in maintaining intracellular ion homeostasis.⁴³ In addition, VARS2, which is upregulated, plays a role in mitochondrial protein synthesis.⁴⁴ However, the cell survival effort did not go well due to the ATP depletion caused by the administration of C. sappan extract.

Conclusion

C. sappan has the capability to inhibit cancer cell growth by inducing apoptosis and downregulation of mitochondrial proteins on A549 cells, including ATP production, respiration, and mitochondrial function. The extract induced expression of genes that involved in the cell growth and cell survival mechanism. However the A549 cells were going to apoptosis after treatment, since the mitochondrial protein that play important role in ATP production were shut down by the extract activity. Further research should be carried out to validate the physiological work of C. sappan.

Data availability

Underlying data

Zenodo: Anticancer effect of Caesalpinia sappan by downregulating mitochondrial genes on A549 lung cancer cell line. https://doi.org/10.5281/zenodo.5732978.³⁹

This project contains the following underlying data:

- C. sappan data.xlsx
- Enrichment RNA Seq C. sappan.xlsx

Data are available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0).

Acknowledgements

Author would thank to Brawijaya University for facilitating this research and Directorate General Higher Education, Ministry of National Education, Indonesia, for providing World Class Research grant.

References

1. de Koning HJ , van der Aalst CM , de Jong PA , et al.: Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. N. Engl. J. Med. 2020; 382(6): 503–513. Publisher Full Text
2. Siegel RL, Miller KD, Jemal A: Cancer statistics, 2020. CA Cancer J. Clin. 2020; 70(1): 7–30. Publisher Full Text
3. Suraya A, Nowak D, Sulistomo AW, et al.: Asbestos-Related Lung Cancer: A Hospital-Based Case-Control Study in Indonesia. Int. J. Environ. Res. Public Health. 2020; 17(2): 591. PubMed Abstract | Publisher Full Text
4. Yuan M, Huang LL, Chen JH, et al.: The emerging treatment landscape of targeted therapy in non-small-cell lung cancer. Signal Transduct. Target. Ther. 2019; 4(1): 61. PubMed Abstract | Publisher Full Text
5. Handayani S, Susidarti RA, Jenie RI, et al.: Two Active Compounds from Caesalpinia sappan L. in Combination with Cisplatin Synergistically Induce Apoptosis and Cell Cycle Arrest on WiDr Cells. Adv. Pharm. Bull. 2017; 7(3): 375–380. PubMed Abstract | Publisher Full Text
6. Lemjabbar-Alaoui H, Hassan OU, Yang YW, et al.: Lung cancer: Biology and treatment options. Biochim. Biophys. Acta BBA - Rev. Cancer. 2015; 1856(2): 189–210. PubMed Abstract | Publisher Full Text
7. Garg V, Dhar VJ, Sharma A, et al.: Facts about standardization of herbal medicine: a review. Zhong Xi Yi Jie He Xue Bao. 2012; 10(10): 1077–1083. PubMed Abstract | Publisher Full Text
8. Nirmal NP, Rajput MS, Prasad RGSV, et al.: Brazilin from Caesalpinia sappan heartwood and its pharmacological activities: A review. Asian Pac J. Trop. Med. 2015; 8(6): 421–430. PubMed Abstract | Publisher Full Text
9. Sembiring EN, Elya B, Sauriasari R: Phytochemical Screening, Total Flavonoid and Total Phenolic Content and Antioxidant Activity of Different Parts of Caesalpinia bonduc (L.) Roxb. Pharm. J. 2017; 10(1): 123–127. Publisher Full Text
10. Naik Bukke A, Nazneen Hadi F, Babu KS, et al.: In vitro studies data on anticancer activity of Caesalpinia sappan L. heartwood and leaf extracts on MCF7 and A549 cell lines. Data Brief. 2018; 19:868–877. PubMed Abstract | Publisher Full Text
11. Lee WJ, Hsiao M, Chang JL, et al.: Quercetin induces mitochondrial-derived apoptosis via reactive oxygen species-mediated ERK activation in HL-60 leukemia cells and xenograft. Arch. Toxicol. 2015; 89(7): 1103–1117. PubMed Abstract | Publisher Full Text
12. Eldeen IMS, Seow EM, Abdullah R, et al.: In vitro antibacterial, antioxidant, total phenolic contents and anti-HIV-1 reverse transcriptase activities of extracts of seven Phyllanthus sp. South Afr. J. Bot. 2011; 77(1): 75–79. Publisher Full Text
13. Weerapreeyakul N, Nonpunya A, Barusrux S, et al.: Evaluation of the anticancer potential of six herbs against a hepatoma cell line. Chin. Med. 2012; 7(1): 15. PubMed Abstract | Publisher Full Text
14. Astirin OP, Prayitno A, Artanti AN, et al.: Single-Dose and Combined-Dose of Nanoparticles from Soursop Leaves (Annona muricata L.) and Sappan Wood (Caesalpinia sappan L.) Induced Apoptosis and Necrosis in HeLA Cells. Pharmacogn. J. 2021; 13(5):1134–1142. Publisher Full Text
15. Nguyen HX, Nguyen MTT, Nguyen TA, et al.: Cleistanthane diterpenes from the seed of Caesalpinia sappan and their antiausterity activity against PANC-1 human pancreatic cancer cell line. Fitoterapia. 2013; 91:148–153. PubMed Abstract | Publisher Full Text
16. Utomo RY, Novarina A, Tirtanirmala P, et al.: Enhancement of Cytotoxicity and Apoptosis Induction of Doxorubicin by Brazilein Containing Fraction of Secang (Caesalpinia sappan L.) on T47D Cells. Indones. J. Cancer Chemoprevention. 2018; 9(1):32. Publisher Full Text
17. Navarini ALF, Chiaradia LD, Mascarello A, et al.: Hydroxychalcones induce apoptosis in B16-F10 melanoma cells via GSH and ATP depletion. Eur. J. Med. Chem. 2009; 44(4): 1630–1637. PubMed Abstract | Publisher Full Text
18. Vermeulen K, Van Bockstaele DR, Berneman ZN: The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer: Cell cycle regulation and deregulation. Cell Prolif. 2003; 36(3): 131–149. PubMed Abstract | Publisher Full Text
19. Park YY, Ahn JH, Cho MG, et al.: ATP depletion during mitotic arrest induces mitotic slippage and APC/CCdh1-dependent cyclin B1 degradation. Exp. Mol. Med. 2018; 50(4): 1–14. PubMed Abstract | Publisher Full Text
20. Wang X, Schröder HC, Müller WEG: Amorphous polyphosphate, a smart bioinspired nano-/bio-material for bone and cartilage regeneration: towards a new paradigm in tissue engineering. J. Mater. Chem. B. 2018; 6(16):2385–2412. PubMed Abstract | Publisher Full Text .
21. Müller WEG, Schröder HC, Wang X: The phosphoanhydride bond: one cornerstone of life. Biochemist. 2019; 41(4): 22–27. Publisher Full Text
22. Hara KY, Kondo A: ATP regulation in bioproduction. Microb. Cell Factories. 2015; 14(1): 198. PubMed Abstract | Publisher Full Text
23. Bertram R, Gram Pedersen M, Luciani DS, et al.: A simplified model for mitochondrial ATP production. J. Theor. Biol. 2006; 243(4): 575–586. PubMed Abstract | Publisher Full Text
24. Zhao R, Jiang S, Zhang L, et al.: Mitochondrial electron transport chain, ROS generation and uncoupling (Review). Int. J. Mol. Med. 2019; 44:3–15. PubMed Abstract | Publisher Full Text .
25. Perez-Gomez R, Magnin V, Mihajlovic Z, et al.: Downregulation of respiratory complex I mediates major signalling changes triggered by TOR activation. Sci. Rep. 2020; 10(1): 4401. PubMed Abstract | Publisher Full Text
26. Chen P, Yu J, Chalmers B, et al.: Pharmacological ascorbate induces cytotoxicity in prostate cancer cells through ATP depletion and induction of autophagy. Anti-Cancer Drugs. 2012; 23(4): 437–444. PubMed Abstract | Publisher Full Text
27. Okegawa T, Pong RC, Li Y, et al.: The role of cell adhesion molecule in cancer progression and its application in cancer therapy. Acta Biochim. Pol. 2004; 51(2): 445–457. PubMed Abstract | Publisher Full Text
28. Du J, Zhang L, Yang Y, et al.: ATP Depletion-induced Actin Rearrangement Reduces Cell Adhesion via p38 MAPK-HSP27 Signaling in Renal Proximal Tubule Cells. Cell. Physiol. Biochem. 2010; 25(4-5): 501–510. PubMed Abstract | Publisher Full Text
29. Loscalzo J: The cellular response to hypoxia: tuning the system with microRNAs. J. Clin. Invest. 2010; 120(11): 3815–3817. PubMed Abstract | Publisher Full Text
30. Yoshimura K, Suzuki Y, Inoue Y, et al.: CD200 and CD200R1 are differentially expressed and have differential prognostic roles in non-small cell lung cancer. OncoImmunology. 2020; 9(1): 1746554. PubMed Abstract | Publisher Full Text
31. Coles SJ, Wang ECY, Man S, et al.: CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia. Leukemia. 2011; 25(5): 792–799. PubMed Abstract | Publisher Full Text
32. Bonsor DA, Beckett D, Sundberg EJ: Structure of the N-terminal dimerization domain of CEACAM7. Acta Crystallogr Sect F Struct Biol Commun. 2015; 71(9): 1169–1175. PubMed Abstract | Publisher Full Text
33. Nagano K: R-spondin signaling as a pivotal regulator of tissue development and homeostasis. Jpn Dent Sci Rev. 2019; 55(1): 80–87. PubMed Abstract | Publisher Full Text
34. Cartoni R, Norsworthy MW, Bei F, et al.: The Mammalian-Specific Protein Armcx1 Regulates Mitochondrial Transport during Axon Regeneration. Neuron. 2016; 92(6): 1294–1307. PubMed Abstract | Publisher Full Text
35. Bertram K, Agafonov DE, Dybkov O, et al.: Cryo-EM Structure of a Pre-catalytic Human Spliceosome Primed for Activation. Cell. 2017; 170(4): 701–713.e11. PubMed Abstract | Publisher Full Text
36. Zhu Y, Wang X, Forouzmand E, et al.: Molecular Mechanisms for CFIm-Mediated Regulation of mRNA Alternative Polyadenylation. Mol. Cell. 2018; 69(1): 62–74.e4. Publisher Full Text
37. Hebebrand M, Hüffmeier U, Trollmann R, et al.: The mutational and phenotypic spectrum of TUBA1A-associated tubulinopathy. Orphanet J. Rare Dis. 2019; 14(1): 38. Publisher Full Text
38. Wang Y, Wen M, Kwon Y, et al.: CUL4A Induces Epithelial–Mesenchymal Transition and Promotes Cancer Metastasis by Regulating ZEB1 Expression. Cancer Res. 2014; 74(2): 520–531. PubMed Abstract | Publisher Full Text
39. Stürner E, Behl C: The Role of the Multifunctional BAG3 Protein in Cellular Protein Quality Control and in Disease. Front. Mol. Neurosci. 2017; 10: 177. PubMed Abstract | Publisher Full Text
40. He W, Wu J, Shi J, et al.: IL22RA1/STAT3 Signaling Promotes Stemness and Tumorigenicity in Pancreatic Cancer. Cancer Res. 2018; 78(12): 3293–3305. Publisher Full Text
41. Jian J, Zheng Z, Zhang K, et al.: Fibromodulin promoted in vitro and in vivo angiogenesis. Biochem. Biophys. Res. Commun. 2013; 436(3): 530–535. PubMed Abstract | Publisher Full Text
42. Yu S, Zhang Y, Li Q, et al.: CLDN6 promotes tumor progression through the YAP1-snail1 axis in gastric cancer. Cell Death Dis. 2019; 10(12): 949. PubMed Abstract | Publisher Full Text
43. Boscia F, D’Avanzo C, Pannaccione A, et al.: Silencing or knocking out the Na+/Ca2+ exchanger-3 (NCX3) impairs oligodendrocyte differentiation. Cell Death Differ. 2012; 19(4): 562–572. PubMed Abstract | Publisher Full Text
44. Ma K, Xie M, He X, et al.: A novel compound heterozygous mutation in VARS2 in a newborn with mitochondrial cardiomyopathy: a case report of a Chinese family. BMC Med. Genet. 2018; 19(1): 202. PubMed Abstract | Publisher Full Text
45. Widodo N, Puspitarini S, Alamsyah A, et al.: Anticancer effect of Caesalpinia sappan by downregulating mitochondrial genes on A549 lung cancer cell line.2021. Publisher Full Text

Comments on this article Comments (0)

Version 2

VERSION 2 PUBLISHED 11 Feb 2022

Author details Author details

¹ Biology Department, Faculty of Mathematics and Natural Sciences, Brawijaya University, Malang, Indonesia
² Faculty of Mathematics and Natural Sciences, Maulana Malik Ibrahim State Islamic University Malang, Malang, Indonesia
³ Chemistry Department, Faculty of Mathematics and Natural Sciences, Brawijaya University, Malang, Indonesia

Nashi Widodo
Roles: Conceptualization, Resources, Software, Supervision, Validation, Writing – Original Draft Preparation, Writing – Review & Editing

Sapti Puspitarini
Roles: Methodology, Project Administration, Writing – Original Draft Preparation, Writing – Review & Editing

Muhammad Hermawan Widyananda
Roles: Data Curation, Writing – Original Draft Preparation

Adzral Alamsyah
Roles: Data Curation, Formal Analysis, Investigation, Methodology, Validation, Writing – Original Draft Preparation

Septian Tri Wicaksono
Roles: Data Curation, Formal Analysis, Methodology

Masruri Masruri
Roles: Funding Acquisition

Yoga Dwi Jatmiko
Roles: Funding Acquisition

Competing interests

No competing interests were disclosed.

Grant information

This work was supported by the Directorate General Higher Education, Ministry of Research and Technology Republic of Indonesia, via a World Class Research grant assigned to Widodo, Yoga Dwi Jatmiko, and Masruri (grant number: 023/E4.1/AK.04.PT/2021).
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Article Versions (2)

version 2

Revised

Published: 25 Aug 2022, 11:169

https://doi.org/10.12688/f1000research.76187.2

version 1

Published: 11 Feb 2022, 11:169

https://doi.org/10.12688/f1000research.76187.1

Copyright

© 2022 Widodo N et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download

Export To

metrics

	Views	Downloads
F1000Research	-	-
PubMed Central Data from PMC are received and updated monthly.	-	-

Citations

0

SEE MORE DETAILS

CITE

how to cite this article

Widodo N, Puspitarini S, Widyananda MH et al. Anticancer activity of Caesalpinia sappan by downregulating mitochondrial genes in A549 lung cancer cell line [version 2; peer review: 2 approved]. F1000Research 2022, 11:169 (https://doi.org/10.12688/f1000research.76187.2)

NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.

track

receive updates on this article

Track an article to receive email alerts on any updates to this article.

Open Peer Review

Version 2

VERSION 2

PUBLISHED 25 Aug 2022

Revised

Views

9

Reviewer Report 12 Sep 2022

Jayarani Fatimah Putri, DAILAB, DBT-AIST International Center for Translational and Environmental Research (DAICENTER), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba, Japan

Approved

https://doi.org/10.5256/f1000research.137648.r148604

I have checked the manuscript and found that this ... Continue reading

CITE

Report a concern

Respond or Comment

Version 1

VERSION 1

PUBLISHED 11 Feb 2022

Views

18

Reviewer Report 04 May 2022

Jayarani Fatimah Putri, DAILAB, DBT-AIST International Center for Translational and Environmental Research (DAICENTER), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba, Japan

Approved with Reservations

https://doi.org/10.5256/f1000research.80153.r134490

General comments:
This is an interesting study and the authors have used the cutting-edge methodology to address the answers. Generally, the paper is well written, clear, concise, and structured. The methods are generally appropriate with two possible exceptions. Clarification ... Continue reading

General comments:
This is an interesting study and the authors have used the cutting-edge methodology to address the answers. Generally, the paper is well written, clear, concise, and structured. The methods are generally appropriate with two possible exceptions. Clarification of a few details and provision of rationale of this particular method of transcriptomic sequencing should be provided. Also, the statistical analysis that was used should be addressed as well. Overall, the results are clear and compelling yet have a few details missing that are listed in specific comments below. The authors make a systematic contribution to the research literature in this area of investigation.

Specific comments:

Repetitive sentences in the Introduction.
Cytotoxicity formula: the detail is missing.
The cell culture media and condition that was used is missing.
The second sentence on RNA extraction, preparation and transcriptome sequencing method does not match with the context.
The authors have established that IC50 (45,19ug/ml) value was used for apoptosis, cell cycle and Bax/Bcl2 assay. That would be make sense if IC50 value is covered for cell toxicity assay and graph. The dose range between 40-80ug/ml should be used to explain that.
The last sentence of fourth paragraph and first sentence of next paragraph after it is sounded vague. Removing any one sentence will be more reasonable.
The authors need to cite references in the discussion, especially in paragraph four.

Is the work clearly and accurately presented and does it cite the current literature?

Yes
Is the study design appropriate and is the work technically sound?

Yes
Are sufficient details of methods and analysis provided to allow replication by others?

Yes
If applicable, is the statistical analysis and its interpretation appropriate?

Partly
Are all the source data underlying the results available to ensure full reproducibility?

Yes
Are the conclusions drawn adequately supported by the results?

Yes

Competing Interests: No competing interests were disclosed.

Reviewer Expertise: My area of expertise is on Molecular Oncology (especially in molecular pathway and protein-protein interactions), Bioinformatics and Human Physiology.

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

CITE

Report a concern

Respond or Comment

Views

26

Reviewer Report 09 Mar 2022

Yi Li, Johns Hopkins University, Baltimore, MD, USA

Approved

https://doi.org/10.5256/f1000research.80153.r124566

C. sappan to the A549 cancer cell line. Results indicate the C. sappan extract effectively slows cell growth and induces cell apoptosis. Gene expression analysis indicates the extract interferes with ATP synthesis in mitochondria, which leads to ATP depletion in ... Continue reading

C. sappan to the A549 cancer cell line. Results indicate the C. sappan extract effectively slows cell growth and induces cell apoptosis. Gene expression analysis indicates the extract interferes with ATP synthesis in mitochondria, which leads to ATP depletion in cells. Overall, this study demonstrates the potential of using C. sappan as an anticancer agent by understanding in vitro cellular responses to different doses of C. sappan. The experiments included in this study are well designed and the methods are documented in excellent detail. The figures presented clearly present the results. This experiment evidence presented in this article strongly supports the conclusion, and the findings would provide important guidance to future works on understanding the molecular mechanisms of the biological effects of C. sappan.

However, several previously published articles have investigated the effects of C. sappan to cancer cell lines ¹ ², including one on the same cell line (A549) ³. Therefore, the major findings and conclusions presented in this article are not entirely novel. These previously published papers are not cited, and the previous findings were not discussed in the article. This article shows additional evidence that leads to findings included in previous studies, which is valuable to the researchers in the field but should not be branded as new findings as in the introduction section in this article. As the article is scientifically sound, I recommend the indexing of this paper, but I suggest the authors make changes in the main text to address this issue.

Additional comments are below.

I assume the control group is using pure ethanol (0 ug/ml extract) in cell cultures but explicitly stating what control group condition is in the method section would be helpful.
“This result is not far from the previous studies that treated T47D, PANC-1, and HeLa cells with C. sappan extract to obtain IC50 values of 68.00, 43.6, and 40.88 μg/mL, respectively.” should have references.
Would including the antioxidant activity of some common antioxidant agents in Table 1 as comparisons help readers understand what the values entail?
Can authors comment on whether they expect the extract would also reduce ATP synthesis in healthy cells?

Is the work clearly and accurately presented and does it cite the current literature?

Partly
Is the study design appropriate and is the work technically sound?

Yes
Are sufficient details of methods and analysis provided to allow replication by others?

Yes
If applicable, is the statistical analysis and its interpretation appropriate?

Yes
Are all the source data underlying the results available to ensure full reproducibility?

Yes
Are the conclusions drawn adequately supported by the results?

Yes

References

1. Hung TM, Dang NH, Dat NT: Methanol extract from Vietnamese Caesalpinia sappan induces apoptosis in HeLa cells.Biol Res. 2014; 47: 20 PubMed Abstract | Publisher Full Text
2. Liu B, Lian H: Integrative Analysis to Uncover the Molecular Mechanisms ofCaesalpinia sappan L. for Anti-Cancer Activity. Natural Product Communications. 2021; 16 (11). Publisher Full Text
3. Naik Bukke A, Nazneen Hadi F, Babu KS, Shankar PC: In vitro studies data on anticancer activity of Caesalpinia sappan L. heartwood and leaf extracts on MCF7 and A549 cell lines.Data Brief. 2018; 19: 868-877 PubMed Abstract | Publisher Full Text

Competing Interests: No competing interests were disclosed.

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

CITE

Report a concern

Respond or Comment

Comments on this article Comments (0)

Version 2

VERSION 2 PUBLISHED 11 Feb 2022

Open Peer Review

Reviewer Status

Reviewer Reports

	Invited Reviewers
	1	2
Version 2 (revision) 25 Aug 22		read
Version 1 11 Feb 22	read	read

Yi Li, Johns Hopkins University, Baltimore, USA
Jayarani Fatimah Putri, National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba, Japan

Comments on this article

All Comments(0)

Add a comment

Sign up for content alerts

Browse by related subjects

Back to all reports

Reviewer Report

9 Views

12 Sep 2022 | for Version 2

Jayarani Fatimah Putri, DAILAB, DBT-AIST International Center for Translational and Environmental Research (DAICENTER), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba, Japan

9 Views Cite this report Responses(0)

Approved

I have checked the manuscript and found that this article has answered and revised all the points I addressed.

Competing Interests

No competing interests were disclosed.

Reviewer Expertise

My area of expertise is on Molecular Oncology (especially in molecular pathway and protein-protein interactions), Bioinformatics and Human Physiology.

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Respond to this report

Responses (0)

Back to all reports

Reviewer Report

18 Views

04 May 2022 | for Version 1

Jayarani Fatimah Putri, DAILAB, DBT-AIST International Center for Translational and Environmental Research (DAICENTER), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba, Japan

18 Views Cite this report Responses(0)

Approved With Reservations

General comments:
This is an interesting study and the authors have used the cutting-edge methodology to address the answers. Generally, the paper is well written, clear, concise, and structured. The methods are generally appropriate with two possible exceptions. Clarification of a few details and provision of rationale of this particular method of transcriptomic sequencing should be provided. Also, the statistical analysis that was used should be addressed as well. Overall, the results are clear and compelling yet have a few details missing that are listed in specific comments below. The authors make a systematic contribution to the research literature in this area of investigation.

Specific comments:

Repetitive sentences in the Introduction.
Cytotoxicity formula: the detail is missing.
The cell culture media and condition that was used is missing.
The second sentence on RNA extraction, preparation and transcriptome sequencing method does not match with the context.
The authors have established that IC50 (45,19ug/ml) value was used for apoptosis, cell cycle and Bax/Bcl2 assay. That would be make sense if IC50 value is covered for cell toxicity assay and graph. The dose range between 40-80ug/ml should be used to explain that.
The last sentence of fourth paragraph and first sentence of next paragraph after it is sounded vague. Removing any one sentence will be more reasonable.
The authors need to cite references in the discussion, especially in paragraph four.

Is the work clearly and accurately presented and does it cite the current literature?

Yes
Is the study design appropriate and is the work technically sound?

Yes
Are sufficient details of methods and analysis provided to allow replication by others?

Yes
If applicable, is the statistical analysis and its interpretation appropriate?

Partly
Are all the source data underlying the results available to ensure full reproducibility?

Yes
Are the conclusions drawn adequately supported by the results?

Yes

Competing Interests

No competing interests were disclosed.

Reviewer Expertise

My area of expertise is on Molecular Oncology (especially in molecular pathway and protein-protein interactions), Bioinformatics and Human Physiology.

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

Respond to this report

Responses (0)

Back to all reports

Reviewer Report

26 Views

09 Mar 2022 | for Version 1

Yi Li, Johns Hopkins University, Baltimore, MD, USA

26 Views Cite this report Responses(0)

Approved

C. sappan to the A549 cancer cell line. Results indicate the C. sappan extract effectively slows cell growth and induces cell apoptosis. Gene expression analysis indicates the extract interferes with ATP synthesis in mitochondria, which leads to ATP depletion in cells. Overall, this study demonstrates the potential of using C. sappan as an anticancer agent by understanding in vitro cellular responses to different doses of C. sappan. The experiments included in this study are well designed and the methods are documented in excellent detail. The figures presented clearly present the results. This experiment evidence presented in this article strongly supports the conclusion, and the findings would provide important guidance to future works on understanding the molecular mechanisms of the biological effects of C. sappan.

However, several previously published articles have investigated the effects of C. sappan to cancer cell lines ¹ ², including one on the same cell line (A549) ³. Therefore, the major findings and conclusions presented in this article are not entirely novel. These previously published papers are not cited, and the previous findings were not discussed in the article. This article shows additional evidence that leads to findings included in previous studies, which is valuable to the researchers in the field but should not be branded as new findings as in the introduction section in this article. As the article is scientifically sound, I recommend the indexing of this paper, but I suggest the authors make changes in the main text to address this issue.

Additional comments are below.

I assume the control group is using pure ethanol (0 ug/ml extract) in cell cultures but explicitly stating what control group condition is in the method section would be helpful.
“This result is not far from the previous studies that treated T47D, PANC-1, and HeLa cells with C. sappan extract to obtain IC50 values of 68.00, 43.6, and 40.88 μg/mL, respectively.” should have references.
Would including the antioxidant activity of some common antioxidant agents in Table 1 as comparisons help readers understand what the values entail?
Can authors comment on whether they expect the extract would also reduce ATP synthesis in healthy cells?

Is the work clearly and accurately presented and does it cite the current literature?

Partly
Is the study design appropriate and is the work technically sound?

Yes
Are sufficient details of methods and analysis provided to allow replication by others?

Yes
If applicable, is the statistical analysis and its interpretation appropriate?

Yes
Are all the source data underlying the results available to ensure full reproducibility?

Yes
Are the conclusions drawn adequately supported by the results?

Yes

References

1. Hung TM, Dang NH, Dat NT: Methanol extract from Vietnamese Caesalpinia sappan induces apoptosis in HeLa cells.Biol Res. 2014; 47: 20 PubMed Abstract | Publisher Full Text
2. Liu B, Lian H: Integrative Analysis to Uncover the Molecular Mechanisms ofCaesalpinia sappan L. for Anti-Cancer Activity. Natural Product Communications. 2021; 16 (11). Publisher Full Text
3. Naik Bukke A, Nazneen Hadi F, Babu KS, Shankar PC: In vitro studies data on anticancer activity of Caesalpinia sappan L. heartwood and leaf extracts on MCF7 and A549 cell lines.Data Brief. 2018; 19: 868-877 PubMed Abstract | Publisher Full Text

Competing Interests

No competing interests were disclosed.

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Respond to this report

Responses (0)

[1] 1. de Koning HJ , van der Aalst CM , de Jong PA , et al.: Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. N. Engl. J. Med. 2020; 382(6): 503–513. Publisher Full Text

[2] 2. Siegel RL, Miller KD, Jemal A: Cancer statistics, 2020. CA Cancer J. Clin. 2020; 70(1): 7–30. Publisher Full Text

[3] 3. Suraya A, Nowak D, Sulistomo AW, et al.: Asbestos-Related Lung Cancer: A Hospital-Based Case-Control Study in Indonesia. Int. J. Environ. Res. Public Health. 2020; 17(2): 591. PubMed Abstract | Publisher Full Text

[4] 4. Yuan M, Huang LL, Chen JH, et al.: The emerging treatment landscape of targeted therapy in non-small-cell lung cancer. Signal Transduct. Target. Ther. 2019; 4(1): 61. PubMed Abstract | Publisher Full Text

[5] 5. Handayani S, Susidarti RA, Jenie RI, et al.: Two Active Compounds from Caesalpinia sappan L. in Combination with Cisplatin Synergistically Induce Apoptosis and Cell Cycle Arrest on WiDr Cells. Adv. Pharm. Bull. 2017; 7(3): 375–380. PubMed Abstract | Publisher Full Text

[6] 6. Lemjabbar-Alaoui H, Hassan OU, Yang YW, et al.: Lung cancer: Biology and treatment options. Biochim. Biophys. Acta BBA - Rev. Cancer. 2015; 1856(2): 189–210. PubMed Abstract | Publisher Full Text

[7] 7. Garg V, Dhar VJ, Sharma A, et al.: Facts about standardization of herbal medicine: a review. Zhong Xi Yi Jie He Xue Bao. 2012; 10(10): 1077–1083. PubMed Abstract | Publisher Full Text

[8] 8. Nirmal NP, Rajput MS, Prasad RGSV, et al.: Brazilin from Caesalpinia sappan heartwood and its pharmacological activities: A review. Asian Pac J. Trop. Med. 2015; 8(6): 421–430. PubMed Abstract | Publisher Full Text

[9] 9. Sembiring EN, Elya B, Sauriasari R: Phytochemical Screening, Total Flavonoid and Total Phenolic Content and Antioxidant Activity of Different Parts of Caesalpinia bonduc (L.) Roxb. Pharm. J. 2017; 10(1): 123–127. Publisher Full Text

[10] 10. Naik Bukke A, Nazneen Hadi F, Babu KS, et al.: In vitro studies data on anticancer activity of Caesalpinia sappan L. heartwood and leaf extracts on MCF7 and A549 cell lines. Data Brief. 2018; 19:868–877. PubMed Abstract | Publisher Full Text

[11] 11. Lee WJ, Hsiao M, Chang JL, et al.: Quercetin induces mitochondrial-derived apoptosis via reactive oxygen species-mediated ERK activation in HL-60 leukemia cells and xenograft. Arch. Toxicol. 2015; 89(7): 1103–1117. PubMed Abstract | Publisher Full Text

[12] 12. Eldeen IMS, Seow EM, Abdullah R, et al.: In vitro antibacterial, antioxidant, total phenolic contents and anti-HIV-1 reverse transcriptase activities of extracts of seven Phyllanthus sp. South Afr. J. Bot. 2011; 77(1): 75–79. Publisher Full Text

[13] 13. Weerapreeyakul N, Nonpunya A, Barusrux S, et al.: Evaluation of the anticancer potential of six herbs against a hepatoma cell line. Chin. Med. 2012; 7(1): 15. PubMed Abstract | Publisher Full Text

[14] 14. Astirin OP, Prayitno A, Artanti AN, et al.: Single-Dose and Combined-Dose of Nanoparticles from Soursop Leaves (Annona muricata L.) and Sappan Wood (Caesalpinia sappan L.) Induced Apoptosis and Necrosis in HeLA Cells. Pharmacogn. J. 2021; 13(5):1134–1142. Publisher Full Text

[15] 15. Nguyen HX, Nguyen MTT, Nguyen TA, et al.: Cleistanthane diterpenes from the seed of Caesalpinia sappan and their antiausterity activity against PANC-1 human pancreatic cancer cell line. Fitoterapia. 2013; 91:148–153. PubMed Abstract | Publisher Full Text

[16] 16. Utomo RY, Novarina A, Tirtanirmala P, et al.: Enhancement of Cytotoxicity and Apoptosis Induction of Doxorubicin by Brazilein Containing Fraction of Secang (Caesalpinia sappan L.) on T47D Cells. Indones. J. Cancer Chemoprevention. 2018; 9(1):32. Publisher Full Text

[17] 17. Navarini ALF, Chiaradia LD, Mascarello A, et al.: Hydroxychalcones induce apoptosis in B16-F10 melanoma cells via GSH and ATP depletion. Eur. J. Med. Chem. 2009; 44(4): 1630–1637. PubMed Abstract | Publisher Full Text

[18] 18. Vermeulen K, Van Bockstaele DR, Berneman ZN: The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer: Cell cycle regulation and deregulation. Cell Prolif. 2003; 36(3): 131–149. PubMed Abstract | Publisher Full Text

[19] 19. Park YY, Ahn JH, Cho MG, et al.: ATP depletion during mitotic arrest induces mitotic slippage and APC/CCdh1-dependent cyclin B1 degradation. Exp. Mol. Med. 2018; 50(4): 1–14. PubMed Abstract | Publisher Full Text

[20] 20. Wang X, Schröder HC, Müller WEG: Amorphous polyphosphate, a smart bioinspired nano-/bio-material for bone and cartilage regeneration: towards a new paradigm in tissue engineering. J. Mater. Chem. B. 2018; 6(16):2385–2412. PubMed Abstract | Publisher Full Text .

[21] 21. Müller WEG, Schröder HC, Wang X: The phosphoanhydride bond: one cornerstone of life. Biochemist. 2019; 41(4): 22–27. Publisher Full Text

[22] 22. Hara KY, Kondo A: ATP regulation in bioproduction. Microb. Cell Factories. 2015; 14(1): 198. PubMed Abstract | Publisher Full Text

[23] 23. Bertram R, Gram Pedersen M, Luciani DS, et al.: A simplified model for mitochondrial ATP production. J. Theor. Biol. 2006; 243(4): 575–586. PubMed Abstract | Publisher Full Text

[24] 24. Zhao R, Jiang S, Zhang L, et al.: Mitochondrial electron transport chain, ROS generation and uncoupling (Review). Int. J. Mol. Med. 2019; 44:3–15. PubMed Abstract | Publisher Full Text .

[25] 25. Perez-Gomez R, Magnin V, Mihajlovic Z, et al.: Downregulation of respiratory complex I mediates major signalling changes triggered by TOR activation. Sci. Rep. 2020; 10(1): 4401. PubMed Abstract | Publisher Full Text

[26] 26. Chen P, Yu J, Chalmers B, et al.: Pharmacological ascorbate induces cytotoxicity in prostate cancer cells through ATP depletion and induction of autophagy. Anti-Cancer Drugs. 2012; 23(4): 437–444. PubMed Abstract | Publisher Full Text

[27] 27. Okegawa T, Pong RC, Li Y, et al.: The role of cell adhesion molecule in cancer progression and its application in cancer therapy. Acta Biochim. Pol. 2004; 51(2): 445–457. PubMed Abstract | Publisher Full Text

[28] 28. Du J, Zhang L, Yang Y, et al.: ATP Depletion-induced Actin Rearrangement Reduces Cell Adhesion via p38 MAPK-HSP27 Signaling in Renal Proximal Tubule Cells. Cell. Physiol. Biochem. 2010; 25(4-5): 501–510. PubMed Abstract | Publisher Full Text

[29] 29. Loscalzo J: The cellular response to hypoxia: tuning the system with microRNAs. J. Clin. Invest. 2010; 120(11): 3815–3817. PubMed Abstract | Publisher Full Text

[30] 30. Yoshimura K, Suzuki Y, Inoue Y, et al.: CD200 and CD200R1 are differentially expressed and have differential prognostic roles in non-small cell lung cancer. OncoImmunology. 2020; 9(1): 1746554. PubMed Abstract | Publisher Full Text

[31] 31. Coles SJ, Wang ECY, Man S, et al.: CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia. Leukemia. 2011; 25(5): 792–799. PubMed Abstract | Publisher Full Text

[32] 32. Bonsor DA, Beckett D, Sundberg EJ: Structure of the N-terminal dimerization domain of CEACAM7. Acta Crystallogr Sect F Struct Biol Commun. 2015; 71(9): 1169–1175. PubMed Abstract | Publisher Full Text

[33] 33. Nagano K: R-spondin signaling as a pivotal regulator of tissue development and homeostasis. Jpn Dent Sci Rev. 2019; 55(1): 80–87. PubMed Abstract | Publisher Full Text

[34] 34. Cartoni R, Norsworthy MW, Bei F, et al.: The Mammalian-Specific Protein Armcx1 Regulates Mitochondrial Transport during Axon Regeneration. Neuron. 2016; 92(6): 1294–1307. PubMed Abstract | Publisher Full Text

[35] 35. Bertram K, Agafonov DE, Dybkov O, et al.: Cryo-EM Structure of a Pre-catalytic Human Spliceosome Primed for Activation. Cell. 2017; 170(4): 701–713.e11. PubMed Abstract | Publisher Full Text

[36] 36. Zhu Y, Wang X, Forouzmand E, et al.: Molecular Mechanisms for CFIm-Mediated Regulation of mRNA Alternative Polyadenylation. Mol. Cell. 2018; 69(1): 62–74.e4. Publisher Full Text

[37] 37. Hebebrand M, Hüffmeier U, Trollmann R, et al.: The mutational and phenotypic spectrum of TUBA1A-associated tubulinopathy. Orphanet J. Rare Dis. 2019; 14(1): 38. Publisher Full Text

[38] 38. Wang Y, Wen M, Kwon Y, et al.: CUL4A Induces Epithelial–Mesenchymal Transition and Promotes Cancer Metastasis by Regulating ZEB1 Expression. Cancer Res. 2014; 74(2): 520–531. PubMed Abstract | Publisher Full Text

[39] 39. Stürner E, Behl C: The Role of the Multifunctional BAG3 Protein in Cellular Protein Quality Control and in Disease. Front. Mol. Neurosci. 2017; 10: 177. PubMed Abstract | Publisher Full Text

[40] 40. He W, Wu J, Shi J, et al.: IL22RA1/STAT3 Signaling Promotes Stemness and Tumorigenicity in Pancreatic Cancer. Cancer Res. 2018; 78(12): 3293–3305. Publisher Full Text

[41] 41. Jian J, Zheng Z, Zhang K, et al.: Fibromodulin promoted in vitro and in vivo angiogenesis. Biochem. Biophys. Res. Commun. 2013; 436(3): 530–535. PubMed Abstract | Publisher Full Text

[42] 42. Yu S, Zhang Y, Li Q, et al.: CLDN6 promotes tumor progression through the YAP1-snail1 axis in gastric cancer. Cell Death Dis. 2019; 10(12): 949. PubMed Abstract | Publisher Full Text

[43] 43. Boscia F, D’Avanzo C, Pannaccione A, et al.: Silencing or knocking out the Na+/Ca2+ exchanger-3 (NCX3) impairs oligodendrocyte differentiation. Cell Death Differ. 2012; 19(4): 562–572. PubMed Abstract | Publisher Full Text

[44] 44. Ma K, Xie M, He X, et al.: A novel compound heterozygous mutation in VARS2 in a newborn with mitochondrial cardiomyopathy: a case report of a Chinese family. BMC Med. Genet. 2018; 19(1): 202. PubMed Abstract | Publisher Full Text

[45] 45. Widodo N, Puspitarini S, Alamsyah A, et al.: Anticancer effect of Caesalpinia sappan by downregulating mitochondrial genes on A549 lung cancer cell line.2021. Publisher Full Text

Anticancer activity of Caesalpinia sappan by downregulating mitochondrial genes in A549 lung cancer cell line

Abstract

Keywords

Revised Amendments from Version 1

Introduction

Methods

Plant and extraction

Cytotoxicity assay

(1)

(2)

Cell cycle, apoptosis, and BAX/BCL-2 ratio assay

2,2–Diphenyl-1-picrylhydrazyl (DPPH) scavenging activity assay

(3)

Total flavonoids assay

Total phenolic assay

RNA extraction, preparation, and transcriptome sequencing

Results

Antioxidant activity, total phenol, and flavonoid content

Table 1. Antioxidant activity and total phenol and flavonoid content of the samples.

Anticancer activity of C. sappan against A549 cells line

Figure 1. Anticancer activity of C. sappan against A549 cells line.

Effect of C. sappan extract on the gene expression profile of A549 cells

Figure 2. Gene expression profile of A549 cells after C. sappan extract treatment for 24 h.

Changes in gene expression profile due to the extract treatment affect the biological processes of A549

Figure 3. Gene expression profile affects the biological processes of A549 cells after C. sappan extract treatment for 24 h.

Network analysis of sixfold up- and downregulated genes

Figure 4. Protein interactions related to cancer on A549 cells after C. sappan extract treatment for 24 h.

Discussion

Conclusion

Data availability

Underlying data

Acknowledgements

References

Comments on this article Comments (0)

Open Peer Review

Comments on this article Comments (0)

Open Peer Review

Reviewer Status

Reviewer Reports

Comments on this article

Browse by related subjects

Competing Interests Policy

Stay Updated